Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Duda

Showing results (331-340 of 338) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 338 results.
Gut|January 12, 2021
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinomaShuichi Aoki, Koetsu Inoue, Sebastian Klein, et al.
Molecular Therapy. Oncology|January 6, 2025
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockadeMulu Z Tesfay, Yuguo Zhang, Khandoker U Ferdous, et al.
Science Translational Medicine|May 26, 2017
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activationDavid P Kodack, Vasileios Askoxylakis, Gino B Ferraro, et al.
JAMA Oncology|May 31, 2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical TrialJanet E Murphy, Jennifer Y Wo, David P Ryan, et al.
Nature Cancer|June 28, 2021
FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASISGino B Ferraro, Ahmed Ali, Alba Luengo, et al.
Nature Cancer|February 5, 2022
Author Correction: Fatty acid synthesis is required for breast cancer brain metastasisGino B Ferraro, Ahmed Ali, Alba Luengo, et al.
Cancer Discovery|July 2, 2017
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of CholangiocarcinomaApinya Jusakul, Ioana Cutcutache, Chern Han Yong, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 34

Showing results (331-340 of 338) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 338 results.
Gut|January 12, 2021
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinomaShuichi Aoki, Koetsu Inoue, Sebastian Klein, et al.
Molecular Therapy. Oncology|January 6, 2025
Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockadeMulu Z Tesfay, Yuguo Zhang, Khandoker U Ferdous, et al.
Science Translational Medicine|May 26, 2017
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activationDavid P Kodack, Vasileios Askoxylakis, Gino B Ferraro, et al.
JAMA Oncology|May 31, 2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical TrialJanet E Murphy, Jennifer Y Wo, David P Ryan, et al.
Nature Cancer|June 28, 2021
FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASISGino B Ferraro, Ahmed Ali, Alba Luengo, et al.
Nature Cancer|February 5, 2022
Author Correction: Fatty acid synthesis is required for breast cancer brain metastasisGino B Ferraro, Ahmed Ali, Alba Luengo, et al.
Cancer Discovery|July 2, 2017
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of CholangiocarcinomaApinya Jusakul, Ioana Cutcutache, Chern Han Yong, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 34